Clinical trial Recruiting at 1 site Observational Ages 18 and up

Analysis of eye and eyelid growths using advanced imaging technology

Official title: Analysis of Videodermatoscopic Parameters of Ocular, Periocular, Conjunctival and Palpebral Neoformations

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06714799 · Data updated 2026-11-12

This study is testing a new imaging technique to help doctors better understand and identify different types of growths on the eyes and eyelids, so they can tell which ones are harmless and which ones might need treatment.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedJune 15, 2021
Main results expectedDecember 15, 2026
Study endsDecember 15, 2030
Registry record updatedDecember 5, 2024
Trial IDNCT06714799 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with specific ocular and periocular conditions such as melanocytic nevus, basal cell carcinoma, and melanoma.

Probably not a fit

Patients with inflammatory conditions or multiple lesions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the detailed examination of ocular, periocular, conjunctival, and eyelid neoformations using videodermatoscopy. By evaluating parameters such as size, shape, color, and internal structure, the study aims to differentiate between benign and potentially harmful lesions. The observational approach allows for a comprehensive assessment of these growths without the need for invasive procedures. The findings could lead to improved diagnostic accuracy and treatment planning for patients with eye-related conditions.

Why it matters

Potential benefit: If successful, this study could enhance the ability to accurately diagnose and manage various eye and eyelid growths, leading to better patient outcomes.

How similar studies have gone: While the use of videodermatoscopy is established in dermatology, this specific application in ocular conditions is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients who had been diagnosed with one of the following conditions in the ocular and periocular region: common melanocytic nevus, melanosis, seborrheic keratosis, viral wart, angioma and angiokeratoma, apocrine hydrocystoma, xanthelasma, steatocystoma, actinic keratosis, basal cell carcinoma, squamous cell carcinoma, melanoma.

Exclusion Criteria:

* Patients who presented with one of the following conditions were excluded from the study: concomitant inflammatory processes, including blepharitis, chalazion, pterygium, pinguecula), coexistence of multiple, periocular or ocular lesions, diagnosis of syndromic diseases related to a major risk for cutaneous neoformations.

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Sabina Vaccari, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Sabina Vaccari, MD
  • Email: sabina.vaccari@aosp.bo.it
  • Phone: 3403646960

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.